feed,title,long_url,short_url
BioRxiv,Impact of South African 501.V2 Variant on SARS-CoV-2 Spike Infectivity and Neutralization: A Structure-based Computational Assessment,https://biorxiv.org/cgi/content/short/2021.01.10.426143v1?rss=1,https://j.mp/3i6ok0F
BioRxiv,Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces shedding of SARS-CoV-2 D614G in rhesus macaques,https://biorxiv.org/cgi/content/short/2021.01.09.426058v1?rss=1,https://j.mp/3icoVOI
BioRxiv,COVID-19 Severity Is Associated with Differential Antibody Fc-mediated Innate Immune Functions,https://biorxiv.org/cgi/content/short/2021.01.11.426209v1?rss=1,https://j.mp/3bySHM6
BioRxiv,Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA SARS 2 S in preclinical vaccination,https://biorxiv.org/cgi/content/short/2021.01.09.426032v1?rss=1,https://j.mp/2Kca2zm
BioRxiv,Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody class,https://biorxiv.org/cgi/content/short/2021.01.11.426218v1?rss=1,https://j.mp/2XzG6jH
BioRxiv,Immunogenicity and Protective Efficacy of an Intranasal Live-attenuated Vaccine Against SARS-CoV-2 in Preclinical Animal Models,https://biorxiv.org/cgi/content/short/2021.01.08.425974v1?rss=1,https://j.mp/39pCCWw
BioRxiv,Molecular Dynamics Analysis of a Flexible Loop at the Binding Interface of the SARS-CoV-2 Spike Protein Receptor-Binding Domain,https://biorxiv.org/cgi/content/short/2021.01.08.425965v1?rss=1,https://j.mp/35wE9IZ
BioRxiv,Potent SARS-CoV-2 Neutralizing Antibodies Directed Against Spike N-Terminal Domain Target a Single Supersite,https://biorxiv.org/cgi/content/short/2021.01.10.426120v1?rss=1,https://j.mp/2LM4MTy
BioRxiv,Hypoxia reduces cell attachment of SARS-CoV-2 spike protein by modulating the expression of ACE2 and heparan sulfate,https://biorxiv.org/cgi/content/short/2021.01.09.426021v1?rss=1,https://j.mp/3nB7rwj
